BACE1 and Alzheimer disease: The study performed by Kang et al. [119] as mentioned above with sulfonamide chalcones identified compound 63 not only as a potent BACE1 inhibitor, but also a moderate AChE/BChE inhibitor, further indicating its potential anti-AD effect.